A carregar...

Targeting histone deacetyalses in the treatment of B- and T-cell malignancies

HDAC inhibitors (HDACI) are now emerging as one of the most promising new classes of drugs for the treatment of select forms of non-Hodgkin’s lymphoma (NHL). They are particularly active in T-cell lymphomas, possibly hodgkin’s lymphoma and indolent B cell lymphomas. Presently, two of these agents, v...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Zain, Jasmine, O’Connor, Owen A.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer US 2010
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3003796/
https://ncbi.nlm.nih.gov/pubmed/21132350
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10637-010-9591-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!